| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |